METTL3 and neoplasm: On the positive side, we have found that targeting METTL3 enhances the killing effect on human melanoma cancer in vivo, and in vitro experiments showed that METTL3 inhibition can augment the killing ability of human T cells against tumours (Figures 6G and S2C).